Article
Advances in development of hypoallergenic latex immunotherapy.
Current opinion in allergy and clinical immunology - 1 Dec 2005
Rolland Jennifer M, Drew Alexander C, O'Hehir Robyn E
Abstract excerpt
PURPOSE OF REVIEW: The characterization of clinically relevant latex allergens and the production of recombinant allergens is now well advanced, but this knowledge needs to be translated into new strategies for the safe and effective specific treatment of latex allergic diseases including asthma and anaphylaxis. RECENT FINDINGS: The current status of latex allergy is discussed indicating a changing demographic...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
